Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  radiation toxicity
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 59 for your search:
Start Over
Phase II/III Randomized Study of Amifostine Followed By Protracted Fractionated Radiotherapy in Patients With Inoperable, Unresectable, or Postoperatively Recurrent Rectal Adenocarcinoma (Summary Last Modified 11/2001)
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to physiologic 74
Sponsor: NCI
Protocol IDs: UPCC-00-A-0465, NCI-T87-0232
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0537, CDR0000592644, NCT00656513
Phase III Double Blind, Placebo Controlled Study of Sucralfate for Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-949252, NCI-P97-0083
Phase III Randomized Study of Biafine Cream vs Standard Care for Radiation-Induced Skin Toxicity in Women Undergoing Breast Irradiation
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9713, NCI-P97-0125
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065974, NCCTG-969256, NCI-P97-0127, NCT00003170
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9801, CDR0000066260, NCT00003313
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9809, CDR0000066979, RTOG-DEV-1016, NCT00003825
Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068206, NCCTG-N99C5, NCI-P00-0169, NCT00006349
Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-9913, CDR0000068312, RTOG-DEV-1073, NCI-P00-0173, NCT00006481
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-9901, CDR0000068406, NCI-P00-0177, NCT00008398
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0191, NCI-2012-02384, CAN-NCIC-CX4, CDR0000068641, U10CA027469, CX4, NCT00017004
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068810, P30CA016042, UCLA-0008049, IBP-PG-015, NCI-G01-2001, NCT00022373
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069337, NCCTG-N01C4, NCI-P02-0224, N01C4, NCT00036881
Phase III Randomized Study of Aloe Vera Gel as a Prophylactic Agent for Radiotherapy-Induced Skin Toxicity in Breast and Pelvic Cancer Patients (Summary Last Modified 02/92)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-909252, MAYO-909252, NCI-P91-0012
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0315, CDR0000349441, NCT00075868
Phase III Randomized Study of Donepezil Hydrochloride in Patients Who Have Undergone Partial- or Whole-Brain Irradiation for Brain Tumors
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCCWFU-91105, WFU 91105°, NCT00369785, WFU-91105
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N06C4, NCI-2012-02708, CDR0000530309, N06C4, NCT00438659
Monoclonal Antibody Therapy in Treating Patients With Leukemia
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000065240, NCI-96-C-0147K, NCT00019227
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068021, NCCTG-N9923, N9923, NCT00006012
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-0022, CDR0000068231, RTOG-H-0022, RTOG-DEV-1065, NCT00006360
Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0116, CDR0000068472, RTOG-C-0116, NCT00012012
Single Agent Armodafinil for Patient-Reported Fatigue
Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: 18 to 64
Sponsor: NCI, Other
Protocol IDs: 2010-0557, R01 026582-26, NCI-2011-00881, NCT01330446
Start Over